Antitumor activity of two gelsemine metabolites in rat liver microsomes

Abstract

Gelsemine is one of the major alkaloids from Gelsemium elegans Benth., which has been used as an antitumor remedy in clinic. In this paper, metabolism of gelsemine has been investigated in vitro in phenobarbital-treated rat liver microsomes. The metabolites of gelsemine were separated and evaluated using the flash silica gel column, preparative HPLC, using NMR and MS methods. According to the spectral data, two metabolites, M1 and M2, were identified as 4-N-demethylgelsemine and 21-oxogelsemine, respectively. By the MTT method in vitro, the antitumor activities between gelsemine and its metabolites were compared in the HepG2 and HeLa cell lines. Moreover, the main metabolic pathway was further proposed.

Keywords:

• gelsemine
• 4-N-demethylgelsemine
• 21-oxogelsemine
• antitumor
• liver microsomes

Acknowledgements

We wish to thank Prof. Qi-Shi Sun of Shenyang Pharmaceutical University, for identification of the plant materials. This work was supported by the Scientific Research Foundation for the Doctoral Scholars (Q.C.Z., No. 20031040), Liaoning, China.